Lonza EBIT soars 11.2% in 2013

The supplier's Specialty Ingredients business delivered a positive performance

Switzerland based supplier Lonza has announced that it remains on track to deliver long term sustainable growth with solid CORE EBIT results in 2013: up 11.2% on the prior year and in line with guidance. According to the company, these results reflect the continued success of its product portfolio optimisation and the execution of efficiency improvement programmes throughout the global organisation.

In 2013, Lonza's operational free cash flow was maintained on a high level at CHF519m. All businesses in Lonza’s two market segments – Specialty Ingredients and Pharma&Biotech – generated operational free cash flow.

Specialty Ingredients was said to have delivered a positive performance, with substantially increased profitability in total and in nearly all markets. Specialty Ingredients’ sales were driven by strong demand for agrochemical offerings and good demand for industrial solutions, as well as the successful conclusion of the Arch integration. These developments helped to balance the significantly lower revenues in the company's Recreational Water business, where the unseasonable weather led to a weak result in all major regions.

Companies